Gerard Brophy - 17 May 2023 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
17 May 2023
Transactions value $
-$399,171
Form type
4
Filing time
19 May 2023, 16:19:37 UTC
Previous filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Tax liability -$399,171 -19,683 -18.11% $20.28 89,032 17 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.